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Fibronectin in the extracellular matrix of tissues acts as a substrate for cell adhesion and migration during development.
Heterogeneity in the structure of ®bronectin is largely due to the alternative splicing of at least three exons (IIIB, IIIA, and
V) during processing of a single primary transcript. Fibronectin mRNA alternative splicing patterns change from B/A/V/
to B/A0V/ during chondrogenesis. In this report, immunohistochemical analysis demonstrates that while ®bronectin
protein containing the region encoded by exon IIIB is present throughout the limb at all stages of development, ®bronectin
protein containing the region encoded by exon IIIA disappears from cartilaginous regions just after condensation in vivo and
in high-density mesenchymal micromass cultures in vitro. Treatment of mesenchymal micromass cultures prior to condensa-
tion with an antibody speci®c for the region encoded by exon IIIA disrupts the formation of cellular condensations and
inhibits subsequent chondrogenesis in a dose- and time-dependent manner. Furthermore, microinjection of the exon IIIA
antibody into embryonic chick limb primordia in vivo results in malformations characterized by smaller limbs and loss of
limb skeletal elements. These results strongly suggest that the presence of the region encoded by exon IIIA in mesenchymal
®bronectin is necessary for the condensation event that occurs during chondrogenesis. q 1997 Academic Press
INTRODUCTION of functional domains with speci®c binding af®nities for
structures such as the cell surface, collagen, ®brin, and
heparin (for reviews see Hynes, 1990; Mosher, 1989). EvenFibronectin (FN),2 a large glycoprotein present in plasma
and the extracellular matrix of most tissues, participates in though the general structure of the ®bronectin monomer
is highly conserved, several different forms of ®bronectinmany critical cellular processes including differentiation,
adhesion, clot formation, and migration. Fibronectin gener- exist including a form present in plasma and multiple cell-
associated forms (for reviews see Hynes, 1990; Mosher,ally exists in the extracellular matrix as a dimer of similar
or identical subunits. Each ®bronectin monomer is com- 1989; Yamada, 1983). Some of the forms differ simply in
the extent or type of glycosylation (Paul and Hynes, 1984).posed of three types of homologous repeating units, the
type I, II, and III elements, that combine to form a series However, much of the heterogeneity in ®bronectin's struc-
ture is due to the alternative splicing of at least three exons
(IIIB, IIIA, and V) during the posttranscriptional processing
of the ®bronectin primary transcript (Schwarzbauer et al.,1 To whom correspondence should be addressed at Department
of Orthopaedic Surgery, Thomas Jefferson University, 1015 Walnut 1983, 1987b; Kornblihtt et al., 1984; Odermatt et al., 1985;
Street, 501 Curtis Building, Philadelphia, PA 19107. Fax: 215-955- Zardi et al., 1987). Two of the alternatively spliced exons
1068. E-mail: bennett3@je¯in.tju.edu. (IIIB and IIIA) can be either entirely present or entirely ab-2 Abbreviations used: CMFSG, Ca2/, Mg2/-free saline plus glu-
sent in the mature ®bronectin mRNA as a result of exoncose; FBS, fetal bovine serum; FN, ®bronectin; PBS, phosphate-
skipping. Multiple splice variations involving complexbuffered saline; PNA, peanut agglutinin; RGD, arginine±glycine±
exon subdivision exist for the third alternatively splicedaspartate; FGF, ®broblast growth factor; HH stage, Hamburger and
exon containing the V (variable) region with the number ofHamilton chick embryonic stage; MBP, maltose binding protein;
N-CAM, neural cell adhesion molecule. possible variations depending on the species. In the chick,
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the entire V region may be included or the ®rst 132 bases quent chondrogenesis. Injection of the exon IIIA antibodies
into the limb primordia of shell-less chick embryos in vivomay be excluded.
Developmental and tissue-speci®c patterns of splicing results in limb malformations characterized by smaller
limbs and the absence of one or more skeletal elements.have been demonstrated with each of the alternatively
spliced regions of the ®bronectin gene in many tissue and Taken together, these results suggest that the region en-
coded by the alternatively spliced exon IIIA in mesenchy-morphogenic processes (Norton and Hynes, 1987; ffrench-
Constant et al., 1988, 1989; Pagani et al., 1991; Magnuson mal ®bronectin is necessary for chondrogenesis, probably
at the level of cellular condensation.et al., 1991; Bennett et al., 1991; DeSimone et al., 1992).
Furthermore, the expression of these alternatively spliced
®bronectin mRNAs generally correlates with the expression
of particular ®bronectin isoforms (Price and Hynes, 1985; MATERIALS AND METHODS
Paul et al., 1986; Schwarzbauer et al., 1987a). These observa-
tions support the idea that the splicing process provides a Chick Embryos
means to create different forms of ®bronectin in the extra-
Fertilized White Leghorn chicken eggs were obtained from Trus-cellular matrix, presumably for functional diversity. For ex-
low Farms (Chestertown, MD) and incubated at 37.57C in a humidi-ample, ®bronectin containing the region encoded by exon
®ed egg incubator for the desired period of time.IIIA increases during the activation of lipocytes into contrac-
tile myoepithelial cells in an in vitro liver ®brosis model
and appears to be required for the wound-healing process in Fibronectin Antibodies
this system (Jarnagin et al., 1994). However, the functional
Three anti-®bronectin antibodies were used as primary antibod-signi®cance of ®bronectin isoform changes in most differen-
ies for the characterization of ®bonectin isoforms in early and latetiation or wound-healing processes has not yet been estab-
stage chick limbs: (A) rabbit polyclonal antibodies raised againstlished (ffrench-Constant, 1995; Kornblihtt et al., 1996).
human plasma ®bronectin from Cappel (Organon Teknika, WestOne of these morphogenic processes, chondrogenesis, ex-
Chester, PA) that recognize all ®bronectin isoforms, (B) a mouse
hibits remarkable tissue and developmental speci®city with monoclonal antibody speci®c for the EDA domain of human cellu-
respect to the alternative splicing of ®bronectin mRNAs. lar ®bronectin from ICN Biomedicals (Irvine, CA) that recognizes
Cartilage differentiation from mesenchymal tissues is char- only the ®bronectin isoforms containing the regions encoded by
acterized by speci®c changes in the extracellular matrix exon IIIA (Vartio et al., 1987), and (C) rabbit polyclonal antibodies
components present in each of these tissues. Mesenchyme raised against the region encoded by exon IIIB in the chick ®bro-
nectin gene (White et al., 1996). These antibodies will hereaftercontains a matrix rich in collagen type I and various types
be referred to as the general ®bronectin antibodies, the exon IIIAof heparan sulfate proteoglycans, while the newly formed
antibody, and the exon IIIB antibodies, respectively. We have showncartilage matrix is composed primarily of collagen types II,
previously that even though the general ®bronectin antibodies andIX, and XI and aggrecan, a large chondroitin sulfate proteo-
the exon IIIA antibody were raised against human ®bronectins,glycan (reviewed in von der Mark, 1980; Mayne, 1989;
these antibodies cross-react with the appropriate ®bronectin iso-
Kuettner, 1992). Fibronectin, a connecting molecule in the forms in the chick (White et al., 1996).
extracellular matrix, is present throughout chondrogenesis.
However, we and others have shown that the structure of
®bronectin changes during chondrogenesis as a result of Immunohistochemical Localization of the
speci®c alternative splicing events (Bennett et al., 1991; Alternatively Spliced Forms of Fibronectin
White et al., 1996; Peters et al., 1996a,b). Speci®cally, all
The distribution of ®bronectin isoforms in paraformaldehyde-of the ®bronectin mRNAs from prechondrogenic limb mes-
®xed, paraf®n-embedded sections of chick limb buds at variousenchyme contains exons IIIB, IIIA, and V (B/A/V/),
stages of development was determined by immunohistochemicalwhereas all of the ®bronectin mRNAs from chick cartilage
staining using a modi®cation of the streptavidin±biotin system of
contain exons IIIB and V but do not contain exon IIIA the Histostain-SP kit (Zymed Laboratories Inc., South San Fran-
(B/A0V/). Furthermore, in situ hybridization with exon- cisco, CA). The Histostain-SP method uses a biotinylated second
speci®c probes reveals that the ®bronectin mRNA splicing antibody, a streptavidin±peroxidase conjugate, and a substrate±
patterns change just after the condensation event that oc- chromagen mixture to demonstrate the antigen in the cells and
tissue. Speci®cally, early, middle, and late limb buds from Hamil-curs during chick limb chondrogenesis both in vivo and in
ton and Hamburger (HH) stages 20, 24, and 30 (Hamburger andvitro (Gehris et al., 1996).
Hamilton, 1951) were removed, rinsed in Dulbecco's phosphate-In this report, we demonstrate that the changes in ®bro-
buffered saline (PBS), and ®xed in 4% paraformaldehyde. The tissuenectin alternative splicing that occur at the mRNA level
was dehydrated in serial dilutions of ethanol and embedded in par-(Bennett et al., 1991; Gehris et al., 1996) correspond to
af®n. Serial sections, 8 mm thick, were cut and mounted on Fisherchanges in ®bronectin isoform expression at the level of the
plus slides, allowed to dry overnight on a 377C slide warmer, and
protein during chondrogenesis in vivo and in vitro. We show stored dry at 47C until use. The slides were deparaf®nized and
further that the addition of antibody or peptide speci®c for washed in 0.1% acetic acid in PBS overnight. The tissue was then
the region encoded by exon IIIA to high-density mesenchy- treated for 40 min with 300 U/ml hyaluronidase (bovine testes,
mal micromass cultures in vitro prior to condensation spe- Worthington Biochemical Co., Freehold, NJ) in 0.1 M sodium ace-
tate buffer, pH 5.5, rinsed in PBS, and blocked with hydrogen perox-ci®cally disrupts cellular condensations and inhibits subse-
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ide in methanol. The method outlined in the kit was then utilized 10% FBS was added to the cultures 2 hr after cell plating. Additional
antibodies used in inhibition studies included a mouse IgG controlwith a 1:100 dilution of each of the primary antibodies (see antibody
section). The secondary antibodies were either anti-mouse or anti- (Sigma); an avian-speci®c anti-®bronectin monoclonal antibody,
B3D6 (Gardner and Fambrough, 1983), with an unmapped epitope,rabbit from the kit. Color development was terminated in water
and the slides were mounted in crystal mount and baked at 807C for obtained from the Developmental Studies Hybridoma Bank (Uni-
versity of Iowa); the 16G3 monoclonal antibody (Nagai et al., 1991)30 min. The slides were viewed on an Olympus BH-2 microscope.
Preimmune serum for the exon IIIB antibodies, mouse IgG, or rabbit speci®c for an epitope mapping near the RGD site on ®bronectin
(a generous gift from K. Yamada, NIH) that cross-reacts with chickserum replaced each of the primary antibodies in sections utilized
as background controls. Staining with a monoclonal antibody spe- ®bronectin isoforms (White and Bennett, unpublished observa-
tions); and our exon IIIB antibodies speci®c for the region encodedci®c for chick collagen type II (Linsenmayer and Hendricks, 1980;
a generous gift of T. Linsenmayer, Tufts University) served as a by the alternatively spliced exon IIIB (White et al., 1996). The extent
of chondrogenesis in the cultures was assessed 24, 48, and 72 hrmarker for differentiated cartilage in vivo and cartilaginous nodules
in vitro. after plating as described above for high-density mesenchymal mi-
cromass cultures.The distribution of ®bronectin isoforms was also determined in
whole-mount paraformaldehyde-®xed high-density mesenchymal In some experiments, the micromass cultures treated with exon
IIIA antibody were rinsed and ®xed 24 and 48 hr after plating asmicromass cultures (see next section) at 24, 48, and 72 hr after
initial cell plating using the Histostain-SP kit as described above described for immunohistochemistry. The location of exon IIIA
antibody binding was then detected using biotin-conjugated sec-for tissue sections.
For immuno¯uorometric colocalization experiments, mesen- ondary anti-mouse antibodies and the Histostain-SP kit (Zymed
Laboratories).chymal cells were initially plated in micromass droplets at a lower
cell density (1 1 106 cells/ml) to facilitate subsequent visualization
by ¯uorescence. In these experiments, rhodamine-conjugated anti-
Peptide Inhibition of Chondrogenesis in Vitromouse secondary antibodies (for the exon IIIA antibody) and ¯uo-
rescein-conjugated anti-rabbit secondary antibodies (for the exon
Fusion proteins corresponding to the regions encoded by exonIIIB antibodies), diluted 1:500 in PBS, were simultaneously incu-
IIIA and exon IIIB with maltose binding protein (MBP) were synthe-bated in the same sample for 10 min in order to visualize the
sized in Escherichia coli and puri®ed from the resulting extractspositions of ®bronectin isoforms containing the regions encoded
as described previously (White et al., 1996). The puri®ed exon IIIA/by exon IIIA and exon IIIB in the same micromass culture. The
MBP and exon IIIB/MBP fusion proteins will hereafter be referredsamples for these experiments were viewed on an Olympus BH-2
to as Peptide A/MBP and Peptide B/MBP, respectively. Peptide A/microscope equipped with epi¯uorescence optics.
MBP and Peptide B/MBP were individually added to high-density
mesenchymal micromass cultures in concentrations ranging from
0.3 to 2.4 mg/ml in Ham's F12 containing 10% FBS 2 hr after initial
High-Density Mesenchymal Micromass Cultures plating of the cells. The extent of chondrogenesis in the cultures
was assessed 72 hr after plating as described above for high-densityMicromass culture is a modi®cation of the system described by
mesenchymal micromass cultures.Ahrens et al. (1977) and San Antonio and Tuan (1986). Limb buds
from HH stage 23/24 chick embryos were removed, cut in half, and
placed in Ca2/, Mg2/-free saline plus glucose (CMFSG) at 377C. The
Histochemical Staining of Peanut Agglutinin-limb buds were enzymatically dissociated in trypsin/collagenase
Binding Cells in Micromass Culturesin CMFSG containing 10% chick serum at 377C for 45±60 min.
The digestion process was terminated with the addition of 5% calf Limb mesenchymal cells were plated in high-density micromass
serum and the mixture was vortexed to disperse the cells. The cell culture as described above and stained with the lectin, peanut ag-
suspension was then passed through a Nitex ®lter and the cells glutinin (PNA), to visualize cellular condensations at 24, 48, and
were pelleted by centrifugation. Cells were resuspended in CMFSG 72 hr after initial cell plating as described previously (Zimmermann
containing 5% calf serum, counted, and plated in 10-ml drops at 10 and Thies, 1984; Stringa and Tuan, 1996). Speci®cally, the cultures
or 20 1 106 cells/ml. The cells were allowed to attach to 12-mm were rinsed with PBS, ®xed with buffered 4% paraformaldehyde,
coverslips (Fisher) sitting in 24-well culture dishes for 2 hr at 377C rinsed again with PBS, and stained with 100 mg/ml peroxidase-
and 5% CO2 and then covered with 1 ml Ham's F12 media con- conjugated PNA (Sigma) for 30 min, washed in PBS, and developed
taining 10% FBS and penicillin (50 U/ml)/streptomycin (50 U/ml). using a Histostain-SP kit (Zymed Laboratories Inc.). The stained
Cultures were assessed 24, 48, and 72 hr after plating for chondro- cultures were viewed and photographed using an Olympus IMT-2
genesis by staining with Alcian blue 8-GX (Sigma) at pH 1.0 as microscope equipped with Hoffman optics.
described (San Antonio and Tuan, 1986) and the expression of colla-
gen type II mRNA by whole-mount in situ hybridization as de-
scribed previously (Gehris et al., 1996). Cultures were then viewed Immunoblots
and photographed using an Olympus IMT-2 microscope equipped
High-density mesenchymal micromass cultures at 0, 24, 48, andwith Hoffman optics.
72 hr after cell plating were extracted with 4 M urea in 0.05 M
phosphate buffer, pH 7.3, and passed through an 18-gauge needle.
Protease inhibitors (4 mM phenylmethanesulfonyl ¯uoride, 2 mMAntibody Inhibition of Chondrogenesis in Vitro
N-ethylmaleimide, 2 mM iodoacetic acid, 100 mM leupeptin, 0.2
IU/ml aprotinin, and 4 mM EDTA, ®nal concentrations) were im-Mesenchymal cells isolated from the limb buds of HH stage 23/
24 chick embryos were plated as described above for high-density mediately added to each extract. The extracts were continuously
dialyzed against PBS overnight using Slide-A-Lyzer 10K dialysismesenchymal micromass cultures. Exon IIIA antibody (in concen-
trations ranging from 0.1 to 1.0 mg/ml) in Ham's F12 containing cassettes (Pierce Chemical Co., Rockford, IL) and proteins were
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determined by the Bradford method using a Coomassie Plus kit thermore, limb mesenchymal cells plated in high-density
(Pierce Chemical Co.). Equal amounts of protein (10 mg) from each micromass cultures proceed through the condensation and
extract were then subjected to SDS±polyacrylamide gel electropho- differentiation stages of chondrogenesis over the course of
resis on an 8% polyacrylamide minigel with a 4% stacking gel 2±3 days according to the same sequence as that of the limb
according to the procedure of Laemmli (1970). The proteins in the bud in vivo (Ahrens et al., 1977; San Antonio and Tuan,
gels were transferred to nitrocellulose (Schleicher and Schuell, Inc.,
1986). Therefore, the developing chick limb and high-den-Keene, NH) using a Mini-Protean II transfer apparatus (Bio-Rad
sity mesenchymal micromass cultures represent ideal sys-Laboratories) in 25 mM Tris base, 190 mM glycine, 20% methanol
tems for examining the relationships between ®bronectinas suggested by the manufacturer. Following transfer, individual,
mRNA alternative splicing and chondrogenesis.identical blots were processed with the general ®bronectin antibod-
ies (1:2000 dilution), the exon IIIA antibody (1:2000 dilution), or Chick limb buds at various stages of development were
the exon IIIB antibodies (1:500 dilution) exactly as described and examined by immunohistochemistry for the presence of
characterized previously (White et al., 1996). each ®bronectin isoform utilizing exon-speci®c antibodies
for ®bronectin. In HH stage 30 limbs, intense collagen type
II staining is associated with cartilaginous regions (Fig. 1A)
Shell-less Chick Embryo Culture as previously reported (von der Mark, 1980) and clearly dis-
tinguishes cartilage and mesenchymal tissues. FibronectinFor in vivo perturbation of limb chondrogenesis with ®bronectin
antibodies, shell-less chick embryos were maintained in shell-less staining is also consistent with previously reported localiza-
culture (Tuan, 1980; Oberlender and Tuan, 1994a). Brie¯y, after 3 tion of ®bronectin in the developing chick limb (Tomasek
days of incubation in ovo, chick embryos were placed without the et al., 1982). Speci®cally, staining with antibodies that rec-
eggshell into ringstands lined with plastic kitchen wrap, covered ognize all ®bronectin isoforms (FN-gen) reveals relatively
with petri dish lids, and maintained in a humidi®ed chamber at homogeneous staining in the mesenchyme of early HH
37.57C with constant air ¯ow. This method permitted easy access
stage 20 limbs (not shown), highly localized staining in re-to the limb and continuous observation of embryonic development.
gions of condensation in HH stage 24 limbs (not shown),
and then general staining in both the cartilage and the sur-
rounding mesenchyme in the HH stage 30 limbs (Fig. 1B).In Vivo Injection of Chick Limb Primordia with
Immunostaining for the regions encoded by exon IIIA andFibronectin Antibodies
exon IIIB is present as early as HH stage 19/20, shortly after
The antibodies were injected into the right limb primordia of limb bud formation, and exhibits a homogeneous staining
HH stage 23/24 chick embryos in shell-less culture using a pulled
throughout the limb mesenchyme (not shown). Similarly,10-ml capillary tube attached to a Hamilton microsyringe mounted
in HH stage 23/24 limbs, ®bronectin protein containingon a micromanipulator (Oberlender and Tuan, 1994a). The volume
exon IIIA and IIIB is distributed throughout the limb (notinjected was typically 0.5 to 1.0 ml (5±10 mg). The antibodies were
shown). In contrast, the ®bronectin protein containing thesuspended in nile blue sulfate to visualize the ef®cacy of each injec-
region encoded by exon IIIA (FN-A) disappears from cartilag-tion. Injected limbs were assessed for chondrogenesis by whole-
mount Alcian blue staining as described below. inous regions of late HH stage 30 limbs (Fig. 1D), while
®bronectin protein containing the region encoded by exon
IIIB (FN-B) remains throughout the cartilage and sur-
Whole-Mount Alcian Blue Staining of Chick rounding mesenchyme (Fig. 1C). These results suggest that
Embryos the ®bronectin protein in prechondrogenic mesenchyme is
B/A/ (mesenchymal ®bronectin), while the ®bronectin inTwo days after injection, the embryos were removed from the
limb cartilage is B/A0 (cartilage ®bronectin), in agreementshell-less culture, ®xed in Carnoy's solution, and subjected to
whole-mount Alcian blue staining (Kimmel and Trammell, 1981; with the ®bronectin mRNA splicing patterns in these tis-
Oberlender and Tuan, 1994a). Brie¯y, the embryos were stained in sues (ffrench-Constant and Hynes, 1989; Bennett et al.,
acid-alcohol Alcian blue for 17 hr, cleared, and macerated in 2% 1991; Gehris et al., 1996) and the characterization of ®bro-
KOH, hardened in 50% glycerol, and stored in 100% glycerin. The nectin isoforms during chick (White et al., 1996) and mouse
limbs were viewed and photographed using a Wild stereo micro- (Peters et al., 1996a,b) development.
scope. All comparisons were made to the contralateral uninjected In micromass cultures in vitro, mesenchymal cells aggre-
limb as well as to the same limb from another embryo injected
gate to form discrete chondrogenic nodules, characterizedwith nonimmune mouse IgG.
by collagen type II immunostaining (Fig. 1E), separated by
®broblasts and myocytes (Ahrens et al., 1977; San Antonio
and Tuan, 1986). At 24 hr after plating, all of the ®bronectinRESULTS
proteins are expressed at low, but detectable, amounts in
both the aggregating mesenchyme and the loose mesen-Immunohistochemical Localization of Fibronectin
chyme in the surrounding areas. The staining for both FN-Isoforms in Chick Limb Buds in Situ and in High-
gen (Fig. 1F) and FN-B (Fig. 1G) in the condensing areasDensity Mesenchymal Micromass Cultures in Vitro
increases as a function of time. These proteins appear
throughout the culture but are most highly expressedThe developing chick limb provides a well-characterized
system for the study of chondrogenesis in vivo (Thorogood within the nodular areas. On the other hand, staining for
FN-A increases in the aggregates until about 48 hr afterand Hinchliffe, 1975; Ede, 1983; Newman et al., 1985). Fur-
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FIG. 1. Immunohistochemical localization of ®bronectin isoforms in the chick limb bud from HH stage 29/30 embryos and high-density
mesenchymal micromass cultures 72 hr after plating. Four closely adjacent longitudinal sections of the chick limb bud from HH stage 29/
30 embryos were stained with an antibody speci®c for collagen type II (A), the general ®bronectin antibodies (B), the exon IIIB antibodies
(C), or the exon IIIA antibody (D) and viewed with bright-®eld optics. Staining for collagen type II demarcates the limb cartilage (c). Prominent
staining with all three ®bronectin antibodies (B±D) was seen in the perichondrium (curved arrows) and the adjacent condensing mesenchyme
(m) surrounding the limb cartilage (c). Staining for general ®bronectin (B) and for ®bronectin containing the region encoded by exon IIIB (C)
remains present in the differentiated cartilage, while ®bronectin containing the region encoded by exon IIIA disappears from the limb
cartilage. A fold in the tissue section is designated by the asterisk (*). Original magni®cation is at 501. High-density mesenchymal micromass
cultures were ®xed for whole-mount immunohistochemistry and stained with an antibody to collagen type II (E), the general ®bronectin
antibodies (F), the exon IIIB antibodies (G), and the exon IIIA antibody (H) 72 hr after plating as described under Materials and Methods.
Cellular aggregation and cartilage nodule formation are indicated by arrows (E±H) and collagen type II staining (E). Staining for general
®bronectin (F) and FN-B is present within the nodules as well as in the internodular spaces (G). In contrast, FN-A staining is present only
in the internodular spaces; staining has disappeared from the nodular areas (H). Original magni®cation is at 501.
plating. The FN-A staining then disappears from the nodu- mass cultures 2 hr after initial cell plating. Three days later,
treated and nontreated cultures were assessed for chondro-lar areas while the surrounding mesenchyme continues to
genesis by Alcian blue staining and in situ hybridizationexpress the protein (Fig. 1H). Therefore, the temporal and
for collagen type II mRNA. Increasing concentrations ofspatial localization of ®bronectin protein containing the re-
the exon IIIA antibody from 0.1 to 1.0 mg/ml decreases thegion encoded by exon IIIA (FN-A) disappears just after con-
number of chondrogenic nodules formed in the cultures asdensation, in agreement with the temporal and spatial local-
viewed by Alcian blue staining (Figs. 2A±2D) and in situization of the FN-A mRNA splicing patterns during chon-
hybridization for collagen type II mRNA (Figs. 2E±2H). Thedrogenesis in vitro (Gehris et al., 1996). The combination
in situ hybridization results suggest that the presence ofof these results implies that the mesenchymal ®bronectin
the antibody does not only inhibit Alcian blue binding toisoform (B/A/) is replaced with the cartilage ®bronectin
aggrecan glycosaminoglycans, but instead re¯ects an actualisoform (B/A0) as a result of a change in ®bronectin mRNA
reduction in cartilage formation. Note that the area of thealternative splicing just after the condensation event that
cultures containing chondrogenic nodules decreases in sizeoccurs during chondrogenesis in vitro exactly as it occurs
with increasing amounts of antibody, suggesting that thein vivo.
antibody blocks cartilage formation most effectively in the
less mature areas of the cultures (outermost regions of the
micromass). Lot to lot variability of the exon IIIA antibodyAntibodies and Peptides Speci®c for the Region
often results in variable inhibition of chondrogenesis (com-Encoded by Exon IIIA in Mesenchymal Fibronectin
pare Fig. 2D with Fig. 4A). However, daily additions of theInhibit Chondrogenesis in Vitro
antibody from any lot (not shown) augments the inhibitory
To assess the functional role of ®bronectin isoforms dur- effect, suggesting that antibody binding to newly synthe-
ing chondrogenesis, we perturbed ®bronectin activity in the sized mesenchymal ®bronectin is necessary to completely
high-density mesenchymal micromass cultures using exon- block chondrogenesis. In contrast, the addition of nonim-
speci®c antibodies. Speci®cally, various ®bronectin anti- mune rabbit IgG antibodies demonstrates no change in the
bodies were added at increasing concentrations to the cul- number of chondrogenic nodules (Fig. 2I), regardless of anti-
body concentration compared to untreated control (Fig. 2A).ture medium of limb mesenchymal cells plated in micro-
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FIG. 3. Peptide inhibition of chondrogenesis in vitro. High-density mesenchymal micromass cultures were treated with 2.4 mg/ml of Peptide
A/MBP, Peptide B/MBP, and MBP (see Materials and Methods) after 2 hr in culture (B±D, respectively) and then stained with Alcian blue
72 hr after plating. Only Peptide A/MBP (B) inhibits chondrogenesis compared to untreated control (A). Original magni®cation is at 251.
To con®rm that the inhibition of chondrogenesis by the 3D) (see Materials and Methods) to the micromass cultures
2 hr after plating also inhibits chondrogenesis in a dose-addition of the exon IIIA antibody is a speci®c effect of the
exon IIIA antibody rather than nonspeci®c effects of any dependent manner with higher concentrations of the pep-
tide having a greater effect on chondrogenesis. These resultsantibody directed against ®bronectin, we completed identi-
cal experiments with several control antibodies. Each prepa- indicate that Peptide A/MBP speci®cally competes for bind-
ing of some unknown molecule(s) to the region encoded byration of antibodies was added at 1 mg/ml to the cultures 2
hr after plating; a description of each antibody appears under exon IIIA present in mesenchymal ®bronectin to exert its
inhibitory effect on chondrogenesis.Materials and Methods. The addition of af®nity-puri®ed
exon IIIB antibodies (Fig. 2J), the 16G3 monoclonal antibody
directed toward an epitope of ®bronectin located close to
The Exon IIIA Antibody Inhibits Formation ofthe RGD site in the type III-10 repeat (Fig. 2L), and the B3D6
Condensations during Chondrogenesismonoclonal antibody directed toward an unmapped epitope
of chick ®bronectin (Fig. 2M) had no effect on chondrogen- The down-regulation of both the FN-A mRNA (Gehris et
al., 1996) and protein (White et al., 1996; Peters et al.,esis suggesting at least a partial speci®city for the region
encoded by exon IIIA in the chondrogenic process. The gen- 1996a,b; Fig. 1) just after condensation in vivo and in vitro
suggests that the inhibition of chondrogenesis resultingeral ®bronectin antibodies (prepared against human plasma
®bronectin which does not contain the regions encoded by from the addition of the exon IIIA antibody prior to conden-
sation might actually be the result of the antibody pre-either exon IIIA or exon IIIB) had only a modest effect on
chondrogenesis (Fig. 2K), consistent with previous reports venting formation of the condensations themselves. Cellu-
lar condensation in vitro begins in the center of the micro-(Frenz et al., 1989a,b) that other regions of the ®bronectin
molecule, such as the heparin-binding domain in the amino- mass cultures at about 18 hr after initial cell plating and
then expands outward toward the periphery so that conden-terminal portion of the ®bronectin molecule (Frenz et al.,
1989a,b), are also involved in the chondrogenic process. The sation is essentially complete in the outermost regions by
about 48±72 hr after plating (San Antonio and Tuan, 1986).combination of these results suggests that the region en-
coded by exon IIIA in mesenchymal ®bronectin, acting pos- Therefore, we performed two additional experiments to ex-
amine more directly the effect of exon IIIA antibody addi-sibly with one or more other domains in the ®bronectin
molecule, is speci®cally required for chondrogenesis. tion on the formation of condensations. First, an experiment
addressing the time-dependence of antibody addition on theThe addition of increasing concentrations of Peptide A/
MBP (Fig. 3B) but not Peptide B/MBP (Fig. 3C) or MBP (Fig. inhibition of chondrogenesis revealed a correlation between
FIG. 2. Dose-dependent exon IIIA antibody inhibition of chondrogenesis in vitro. High-density mesenchymal micromass cultures were
treated with increasing amounts (0.125, 0.25, 0.5, and 1 mg/ml) of exon IIIA antibody 2 hr after plating and stained for the presence of
sulfated proteoglycans by Alcian blue (A±D, respectively) and then subjected to in situ hybridization for collagen type II mRNA (E±H,
respectively) 72 hr after plating. Note the dose-dependent inhibition of chondrogenesis in these cultures with increasing concentrations
of the exon IIIA antibody. I±M illustrate micromass cultures treated with 1 mg/ml mouse IgG (I), the exon IIIB antibodies (J), the general
®bronectin antibodies (K), the 16G3 monoclonal antibody speci®c for an epitope mapping near the RGD site on ®bronectin (L), and the
B3D6 avian-speci®c anti-®bronectin monoclonal antibody with an unmapped epitope (M) 2 hr after initial cell plating and then stained
with Alcian blue 72 hr after plating. Note that only the general ®bronectin antibodies (K) had any observable effect on the area of the
culture undergoing chondrogenesis compared to untreated controls within each individual experiment (example shown in L); the intensity
of Alcian blue staining often varies from one experiment to another. Original magni®cation is at 251.
Copyright q 1997 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8693 / 6x2e$$$$41 10-06-97 10:26:49 dbal
198 Gehris et al.
FIG. 4. Time-dependent exon IIIA antibody inhibition of chondrogenesis in vitro. High-density mesenchymal micromass cultures were
treated with 1 mg/ml of the exon IIIA antibody after 2, 18, and 42 hr in culture (A±C, respectively) or no antibody (D) and then stained
with Alcian blue 72 hr after plating. Original magni®cation is at 251.
the time of antibody addition and the area of the micromass drocyte precursors in the precartilage condensations prior
to deposition of cartilage-speci®c extracellular matrix mate-culture that undergoes chondrogenesis. Speci®cally, the ad-
dition of the exon IIIA antibody at earlier times after plating rials (Zimmermann and Thies, 1984; Aulthouse and So-
lursh, 1987; Milaire, 1991). Because PNA staining is thoughtdecreases the area of the culture that forms nodules (com-
pare 2 hr versus 18 hr after plating in Figs. 4A and 4B, to demarcate cellular condensations during the develop-
ment of skeletal tissues, this method provides a visual as-respectively). Furthermore, antibody addition following
condensation (42 hr after plating in Fig. 4C) has essentially sessment of condensation formation in the cultures (Hall
and Miyake, 1992,1995). Micromass cultures were treatedno effect on nodule formation (compare to no treatment in
Fig. 4D). Together, these results suggest that the antibody with 1 mg/ml exon IIIA antibody (Fig. 5, left half of each
panel) or no antibody (Fig. 5, right half of each panel) 2 hrmay inhibit nodule formation by binding ®bronectin pres-
ent in regions of mesenchymal cells undergoing active con- after plating. Antibody-treated and untreated cultures were
then assessed for cellular condensation by PNA stainingdensation and thus preventing further formation of the con-
densations in the expanding cultures. (Fig. 5, top row) and for chondrogenesis by Alcian blue stain-
ing of the cartilaginous nodules (Fig. 5, bottom row) 24 hrThe effect of the exon IIIA antibody on cellular condensa-
tion was further assessed by staining with PNA, a galactose- (Fig. 5, left panel), 48 hr (Fig. 5, middle panel), and 72 hr
(Fig. 5, right panel) after plating. PNA staining of condensa-speci®c lectin, as described under Materials and Methods.
PNA binds speci®cally to the surfaces of presumptive chon- tions in the center of untreated cultures appears organized
FIG. 5. Localization of precartilage condensations in micromass cultures by PNA binding. High-density mesenchymal micromass cultures
were incubated in the presence (left half of each panel) and absence (right half of each panel) of 1 mg/ml exon IIIA antibody added 2 hr after
cell plating and then stained with PNA-peroxidase (top row) as described under Materials and Methods or Alcian blue (bottom row) 24 hr
(left panel), 48 hr (middle panel), and 72 hr (right panel) after plating. The addition of the exon IIIA antibody inhibits formation of cartilaginous
nodules exhibited by Alcian blue staining (compare bottom left with bottom right in each panel) and disrupts condensation formation as
exhibited by PNA staining (compare top left with top right in each panel) with time in culture. Original magni®cation is at 501.
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by 24 hr (Fig. 5C) and continues to accumulate in the center of ®bronectin increase with time in culture and the amount
of mesenchymal ®bronectin present in the 48-hr extracts is(Figs. 5G and 5K) and expand outward toward the periphery
of the cultures with time. Alcian blue staining of parallel signi®cantly greater than the amount in the 24-hr extracts.
The combination of these results suggests that the exonuntreated cultures demonstrates the normal progressive for-
mation of cartilaginous nodules over the same 3-day culture IIIA antibody may not inhibit condensation initiation in the
center of the cultures, visualized by PNA staining (compareperiod (Fig. 5, bottom right of each panel).
The addition of the exon IIIA antibody to the high-density Figs. 5A and 5C), most likely because of insuf®cient
amounts of ®bronectin that has been resynthesized and de-micromass cultures 2 hr after plating alters both the PNA
and Alcian blue staining patterns over the course of the posited into the matrix by 24 hr after plating. In any event,
the results of the PNA staining, combined with the resultsculture period. Speci®cally, the formation of cartilaginous
nodules is dramatically inhibited in antibody-treated cul- of the temporal studies of exon IIIA antibody addition, sug-
gest that the inhibition of chondrogenesis in the presencetures compared to the untreated control cultures at each
time point (Fig. 5, compare cultures treated with antibody of the exon IIIA antibody occurs during the condensation
event. Thus, the region encoded by exon IIIA in mesenchy-in the bottom left corner with untreated cultures in the
bottom right corner of each panel), in agreement with re- mal ®bronectin appears to be involved in cellular condensa-
tion that occurs during chondrogenesis.sults shown in Fig. 2. Note that the sizes of individual carti-
laginous nodules are substantially smaller in the treated
cultures than in untreated cultures (compare Fig. 5J to 5L),
The Exon IIIA Antibody Perturbs Chondrogenesissuggesting that the exon IIIA antibody inhibits the size as
in the Developing Chick Embryonic Limbwell as the number (see Fig. 2) of chondrogenic nodules
in the cultures. The PNA staining of the antibody-treated Since the exon IIIA antibody inhibits chondrogenesis in
vitro (Fig. 2), we wanted to determine whether perturbationcultures, however, indicates that condensation initiation
occurs equally well in the center of the cultures after 24 hr of mesenchymal ®bronectin function with the exon IIIA
antibody would also inhibit chondrogenesis in vivo. The(compare Fig. 5A with 5C), but then the central condensa-
tions appear to become progressively disrupted after 48 and exon IIIA antibody was injected into the limbs of shell-less
chick embryos (Tuan, 1980) at HH stage 22±23, correspond-72 hr (compare Figs. 5E and 5G with 5I and 5K, respectively),
while peripheral condensations never initiate. Thus, the ing to the time of active cellular condensation and when
the ®bronectin present in the mesenchyme contains theexon IIIA antibody appears to affect formation and mainte-
nance of precartilage condensations. region encoded by exon IIIA. Interestingly, injection of the
exon IIIA antibody appears to disrupt normal limb chondro-Because the micromass cultures consist of cells enzymati-
cally dissociated from the limb buds, we examined whether genesis resulting in moderate to severe skeletal malforma-
tions 2 days after exon IIIA antibody injection into the fore-the absence of exon IIIA antibody interference with initial
mesenchymal cell aggregation after 24 hr of micromass cul- and hindlimbs of the embryos (Fig. 7). In one representative
experiment, 10 of the 12 embryos injected with the exonture (Fig. 5A) might be related to the resynthesis and matrix
deposition of mesenchymal ®bronectin during this initial IIIA antibody (83%) exhibited some degree of limb defor-
mity. In contrast, none of the embryos injected with thephase of culture. Speci®cally, we performed three different
experiments as a means to compare the amount of mesen- exon IIIB antibodies (®ve embryos), mouse IgG (®ve em-
bryos), or dye alone (®ve embryos) exhibited any malforma-chymal ®bronectin present in the matrix at 24 and 48 hr.
First, we localized exactly where the exon IIIA antibody tions. Thus, the malformations do not appear to be the re-
sult of the injection procedure or blocking of the regionbinds within the treated cultures at 24 and 48 hr using a
biotinylated goat anti-mouse IgG secondary antibody (Fig. encoded by the alternatively spliced exon IIIB in mesenchy-
mal ®bronectin.6A). The results showed very little, if any, staining above
background after 24 hr of culture (compare Fig. 6A with Fig. Several of the limbs injected with the exon IIIA antibody
appear small (Figs. 7B, 7C, and 7F), while others are more6B), compared to the readily detectable signal in the matrix
at 48 hr (compare Fig. 6C with Fig. 6D). Second, we immuno- misshapened (Figs. 7D and 7E). Alcian blue staining of the
limbs injected with the exon IIIA antibody and their respec-¯uorescently colocalized ®bronectin containing the regions
encoded by exon IIIA (rhodamine label) and exon IIIB (¯uo- tive contralateral control limbs (Figs. 7D±7F) reveals the
absence of one or more skeletal elements in the antibody-rescent label) at 24 and 48 hr after plating (Fig. 6B). At both
time points, the signals for the regions encoded by exon IIIA injected limbs. For example, the injected limb in Fig. 7D
has a shorter ®bula and tibia, an underdeveloped ®bulare,and exon IIIB codistribute, indicating that the ®bronectin
present in the cultures is actually mesenchymal ®bronectin a shortened humerus, and a missing digit (see Figs. 7E and
7F for additional examples). The limbs injected with equiva-and not an isoform of ®bronectin that does not contain exon
IIIA. In addition, more mesenchymal ®bronectin is clearly lent concentrations of nonimmune rabbit IgG (Fig. 7I), the
exon IIIB antibodies (Fig. 7G), or dye alone (Fig. 7H) did notpresent in the matrix of the cultures after 48 hr than after
24 hr (compare Figs. 6E and 6F with 6G and 6H). Finally, show any changes in morphology or Alcian blue staining
compared to contralateral uninjected control limbs.Western immunoblot analysis of 4 M urea extracts from the
micromass cultures at 0, 24, 48, and 72 hr with the general, The combination of the in vitro and in vivo results
strongly suggests that the region encoded by exon IIIA pres-exon IIIA, and exon IIIB antibodies shows that the amounts
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FIG. 6. Localization and levels of mesenchymal ®bronectin in mesenchymal micromass cultures. (A) Two hours after initial cell plating,
high-density mesenchymal micromass cultures were incubated in the presence (a and c) and absence (b and d) of exon IIIA antibody. The exon
IIIA antibody-treated and untreated (no ®rst antibody background controls) cultures were then rinsed and ®xed for immunohistochemistry as
described under Materials and Methods after 24 hr (a, b) or 48 hr (c, d) in culture. The binding locations of the exon IIIA antibody in the treated
and untreated cultures were then visualized with a biotin-conjugated secondary anti-mouse antibody (a±d) or no secondary antibody (not shown)
and the Histostain-SP kit as described under Materials and Methods. Original magni®cation is at 501. (B) Mesenchymal cells were plated at
lower cell density to facilitate visualization by ¯uorescence as described under Materials and Methods. After 24 hr (e and f) and 48 hr (g and
h), cultures were incubated simultaneously with both the exon IIIA and exon IIIB antibodies. The exon IIIA antibody was then visualized with
a rhodamine-conjugated goat anti-mouse antibody (e and g), while the exon IIIB antibody was visualized with a ¯uorescein-conjugated goat
anti-rabbit antibody (f and h) as described under Materials and Methods. Original magni®cation is at 501; the bar represents 50 mm. (C) Extracts
were prepared from 0-, 24-, 48-, and 72-hr high-density mesenchymal micromass cultures as described under Materials and Methods. Equal
amounts of protein (10 mg/lane) from each extract were then separated on 8% polyacrylamide minigels and subjected to SDS±polyacrylamide
gel electrophoresis. The separated proteins were then transferred to nitrocellulose and the immunoblots processed with the general ®bronectin
antibodies (top), the exon IIIA antibody (middle), and the exon IIIB antibodies (bottom) as described under Materials and Methods.
FIG. 7. Exon IIIA antibody inhibition of chondrogenesis in vivo. Limb primordia from HH stage 22±23 shell-less chick embryos were injected
with 1 mg exon IIIA antibody, cultured for an additional 2 days, and then subjected to whole-mount Alcian blue staining as described under
Materials and Methods. (A) Uninjected embryo; arrow indicates antibody injection site in the hindlimb of an HH stage 23 embryo. (B) Embryo
2 days after exon IIIA antibody injection into the forelimb (arrow) compared to the hindlimb of the same embryo. (C) Embryo 2 days after
exon IIIA antibody injection into the forelimb (arrow) compared to the contralateral uninjected forelimb of the same embryo. D±F illustrate
examples of the effects of antibody injections on the morphology of the primitive hindlimb (D and E) and the forelimb (F) after Alcian blue
staining compared to the respective contralateral uninjected limbs from the same embryos. In D, the injected limb (right) has a shorter ®bula
(f) and tibia (t), an underdeveloped ®bulare (®), a shortened humerus, and a missing digit (arrow). In E, the injected limb (left) is missing the
®bulare, both the ®bula and tibia are small, and one digit is missing. In F, the Alcian blue-stained forelimb from the embryo shown in C
(bottom) exhibits gross skeletal deformity including a marked reduction in size of all the skeletal elements as well as the digits compared to
the contralateral control (right). G±I illustrate limbs injected with the exon IIIB antibodies, dye alone, and mouse IgG, respectively. None of
the injected limbs (left) show any malformations compared to the contralateral controls (right). f, ®bula; ®; ®bulare; t, tibia.
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ent in mesenchymal ®bronectin is necessary for chondro- aggregation is directly correlated with the extent of cartilage
genesis. Furthermore, the time dependency of exon IIIA an- nodule formation in mesenchymal cells undergoing chon-
tibody addition and the alteration in PNA staining follow- drogenesis in vitro (Solursh, 1983). Other adhesion mole-
ing exon IIIA addition in the high-density mesenchymal cules besides ®bronectin, such as N-cadherin (Oberlender
micromass cultures suggest that this region in mesenchy- and Tuan, 1994a,b) and N-CAM (Widelitz et al., 1993), have
mal ®bronectin is speci®cally required for some aspect of also been implicated in this condensation process. How-
the condensation event that occurs during chondrogenesis. ever, because ®bronectin primarily functions in matrix±
matrix or cell±matrix interactions and N-cadherin and N-
CAM primarily function in cell±cell interactions, they each
DISCUSSION probably contribute to different aspects of the condensation
process. Since mesenchymal ®bronectin is already present
Alternative RNA splicing during developmental pro- before the transient expression of N-cadherin and N-CAM
cesses appears to provide a mechanism for the creation of in vivo, one might expect that ®bronectin would be respon-
protein heterogeneity. Structural diversity of ®bronectin, sible for initially bringing the mesenchymal cells into close
resulting from the alternative splicing of exon IIIA, occurs proximity to each other so that subsequent cell±cell inter-
during chondrogenesis, the differentiation of mesenchyme actions mediated by N-cadherin and N-CAM could be initi-
into cartilage (Bennett et al., 1991). Speci®cally, the splicing ated for completion of the condensation event. However,
patterns of ®bronectin mRNAs change from B/A/V/ in PNA staining to visualize cellular condensations in the
mesenchyme to B/A0V/ in differentiated cartilage just mesenchymal micromass cultures treated with the exon
after the condensation event that occurs during chondro- IIIA antibody suggests that cell aggregates form initially
genesis (Gehris et al., 1996). In this report, we have con- (while mesenchymal ®bronectin levels are still very low
®rmed by immunohistochemical localization with exon- following enzymatic dissociation of the limb buds) and then
speci®c antibodies that the ®bronectin isoforms at the pro- become disrupted (Fig. 5) as ®bronectin levels increase (Fig.
tein level change during chondrogenesis in the developing 6). These results are consistent with N-cadherin and/or N-
chick limb in vivo and in high-density mesenchymal micro- CAM being responsible for the initial aggregation phase in
mass cultures in vitro (Fig. 1), exactly as the splicing pat- vitro and then mesenchymal ®bronectin playing a role in
terns of the ®bronectin mRNAs change in these systems the secondary recruitment phase of condensation formation
(Gehris et al., 1996). Speci®cally, the region encoded by when additional mesenchymal cells are brought into the
exon IIIA is present in ®bronectin mRNAs prior to conden- initial cell aggregates (Solursh et al., 1982). The correlation
sation (mesenchymal ®bronectin) and then disappears just between this in vitro scenario and the in vivo develop-
after condensation (cartilage ®bronectin). Thus, the devel-
mental program remains for further investigation.
opmental timing of this change in ®bronectin isoform struc-
Our immunohistochemical localization of ®bronectinture during chondrogenesis (Fig. 1 and Gehris et al., 1996),
isoforms at different stages of chick limb development indi-coupled with the increase in the expression of ®bronectin
cates that mesenchymal ®bronectin (B/A/V/) is presentcoincident with cellular condensation (Searls et al., 1973;
throughout the early limb mesenchyme (not shown) andThorogood and Hinchliffe, 1975; Kulyk et al., 1989), sug-
then increases dramatically in the areas of active condensa-gests that the presence of the region encoded by exon IIIA
tion (Fig. 1), consistent with previous ®bronectin immuno-in mesenchymal ®bronectin may be necessary for the con-
localization studies (Searls, 1973; Thorogood anddensation event itself and ultimately for the chondrogenic
Hinchliffe, 1975; Dessau et al., 1980; Melnick et al., 1981;process.
Kosher et al., 1982; Tomasek et al., 1982; Kulyk et al., 1989).We have tested this hypothesis by perturbing chondrogen-
Because the structure of the ®bronectin in the actively con-esis in vitro and in vivo with exon-speci®c antibodies to
densing mesenchyme is no different than the ®bronectin®bronectin. The addition of the exon IIIA antibody inhibits
in the noncondensing mesenchyme, the region encoded bychondrogenesis in vitro (Fig. 2) and in vivo (Fig. 7). The
exon IIIA obviously does not determine which mesenchy-timing of the exon IIIA antibody addition also has an effect
mal cell subpopulation will form condensations. However,on chondrogenesis; addition of the exon IIIA antibody prior
the levels of expression of mesenchymal ®bronectin and/orto condensation inhibits nodule formation in actively con-
expression of a speci®c receptor for mesenchymal ®bronec-densing areas (Fig. 3). Furthermore, exon IIIA antibody addi-
tin remain viable possibilities for these determining factors.tion to high-density mesenchymal micromass cultures dis-
The fact that the addition of Peptide A/MBP to high-densityrupts the pattern of PNA staining (Fig. 5), a visual assess-
mesenchymal micromass cultures inhibits chondrogenesisment of condensations. Thus, the time dependency of exon
(Fig. 3B) similar to the addition of exon IIIA antibody sug-IIIA antibody addition on chondrogenesis combined with
gests that either another matrix component or a moleculethe altered PNA staining in exon IIIA antibody-treated cul-
on the mesenchymal cell surface binds directly to the regiontures supports our hypothesis that the region encoded by
encoded by exon IIIA in mesenchymal ®bronectin. The pos-exon IIIA plays a role during the cellular condensation phase
sibility that a speci®c receptor for this region may exist andof chondrogenesis.
serve not only as a marker for condensation, but also toThe precartilage condensation appears absolutely neces-
sary for overt chondrogenesis since the extent of cellular facilitate the condensation process by interacting with the
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